T2DM
2 competing products in clinical development for T2DM.
Pipeline by Phase
Phase 32
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Metformin + Alogliptin + empagliflozin | Celltrion | Phase 3 | Recruiting | 77 |
| CT-L03 Group 1 + CT-L03 Group 2 + Placebo + Empagliflozin + Metformin | Celltrion | Phase 3 | Active | 77 |